Hilltop National Bank’s Novo Nordisk NVO Stock Holding History

Hilltop National Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.3K	Hold	1,716	–	–	0.02%	399
2026 Q1	$63.1K	Sell	1,716 -1,404	-45%	-$66.5K	0.02%	438
2025 Q4	$159K	Sell	3,120 -156	-5%	-$7.98K	0.04%	261
2025 Q3	$182K	Sell	3,276 -1	-0%	-$59	0.04%	244
2025 Q2	$226K	Buy	+3,277	New	+$223K	0.06%	214
2024 Q4	$1.77M	Sell	20,576 -122	-0.6%	-$13.2K	0.53%	49
2024 Q3	$2.46M	Buy	20,698 +309	+2%	+$41.2K	0.75%	28
2024 Q2	$2.91M	Buy	20,389 +1,156	+6%	+$153K	0.94%	19
2024 Q1	$2.47M	Buy	+19,233	New	+$2.29M	0.84%	20

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

OFA

Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Hilltop National Bank's NVO Position: Q2 2026 in Review

Hilltop National Bank held its Novo Nordisk (NVO) position steady in Q2 2026 at 1,716 shares worth $82.3K. The position accounts for 0.02% of the portfolio, ranked #399.

Hilltop National Bank first reported a position in NVO in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.91M in Q2 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Hilltop National Bank held 1,716 shares of Novo Nordisk worth $82.3K as of Q2 2026.
Hilltop National Bank left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.02% of Hilltop National Bank's portfolio in Q2 2026, its #399 holding.
Hilltop National Bank first reported a position in Novo Nordisk in Q1 2024 and has held it in 9 quarters since.
Hilltop National Bank's Novo Nordisk position peaked at $2.91M in Q2 2024.
387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.